Kidneys have long been recognized as a major source of plasminogen activators (PAs). However, neither the sites of synthesis of the enzymes nor their role in renal function have been elucidated. By the combined use of zymographies on tissue sections and in situ hybridizations, we have explored the cellular distribution of urokinase-type (u-PA) and tissue-type (t-PA) plasminogen activators and of their mRNAs in developing and adult mouse kidneys. In 17.5-d old embryos, renal tubules synthesize u-PA, while S-shaped bodies produce t-PA. In the adult kidney, u-PA is synthesized and released in urine by the epithelial cells lining the straight parts of both proximal and distal tubules. In contrast, t-PA is produced by glomerular cells and by epithelial cells lining the distal part of collecting ducts. The precise segmental distribution of PAs suggests that both enzymes may be implicated in the maintenance of tubular patency, by catalyzing extracellular proteolysis to prevent or circumvent protein precipitation. (J. Clin. Invest. 1991. 87:962-970.)
Introduction
Plasminogen activators (PAs)' are serine proteases that convert plasminogen, a widely distributed zymogen, into plasmin, a trypsin-like protease of broad specificity. Two types of PAs have been identified in mammalian cells: they are produced from two related but distinct genes and are referred to as u-PA (urokinase-type) and t-PA (tissue-type) (1) (2) (3) . Though they share similar catalytic activities, u-PA and t-PA differ in their Mr, immunological reactivities, and interactions with other proteins, such as extracellular matrix components and cell surface binding sites. u-PA, which is produced and secreted by a variety of cell types, including monocytes/macrophages (4, 5) , trophoblasts (6, 7) , and epithelial cells (for review see 2) , is considered to participate in the extracellular proteolysis accompanying tissue remodeling and cellular invasion (1, 2, 8) . In contrast, t-PA, which has a high affinity for fibrin (9, 10) and which is synthesized by endothelial cells in normal blood vessels (1 1), is thought to be predominantly involved in fibrinolysis.
There is abundant experimental evidence to implicate PAs in the renal biology of mammals. Indeed, the first PA to be identified was from human urine, which led to its denomination as urokinase (12) . Epithelial cell lines derived from renal tissues ofvarious mammalian species have since been shown to synthesize and release u-PA (13, 14) . Immunohistochemical studies performed on mouse tissues have localized u-PA immunoreactivity to renal tubules (15) , while biochemical and immunohistochemical investigations have detected mainly t-PA, but also u-PA, in human glomeruli (16) (17) (18) . These cumulated observations suggest that PAs might fulfill essential functions in the urinary tract. However, in the aforementioned studies, the cellular sites of synthesis for PAs were not precisely determined: since PAs are secreted proteins, which can interact with extracellular matrix components (9, 19) , cell surface receptors (20, 21) , and specific inhibitors (5, 8, (22) (23) (24) , localization data based on protein estimations are difficult to interpret.
To assess the cellular localizations of u-PA and t-PA mRNAs during mouse nephrogenesis and in the adult kidney, we performed in situ hybridizations on cryostat tissue sections, with specific cRNA probes for u-PA and t-PA. Concomitantly, we applied to corresponding tissue sections a highly sensitive zymographic assay, which allows the detection of PA enzymatic activities at the histological level. We report here that u-PA and t-PA are synthesized and released in urine by distinct portions of the urinary tubules, and that a compartmentalized distribution of PAs is already apparent in embryonic kidneys.
Methods
Material. Kidneys, ureters, and bladders were collected from adult NMRI mice, dissected, embedded in Tissue-Tek (Miles Ames Div., Elkhart, IN), frozen down in precooled methylbutane, and stored at -70°C. Excreted urine was obtained from urethral discharge after animal handling. Pelvic urine was collected through the renal pelvis of anesthesized animals with a glass pipette after ureteral ligature.
Pregnant mice were killed on days 15 and 17 ofgestation to obtain 15.5 and 17.5-d old embryos (25) . Embryos were dissected from the uteri, embedded, and stored as above.
Enzymatic analyses. Protein extraction, immunoprecipitation, gel electrophoresis, and zymography were performed as described (26) .
For zymographies on cryostat tissue sections, the overlay mixture (27) consisted of: 0.5 ml of an 8% commercial instant nonfat dry milk solution (the 8% stock solution in PBS was heated at 95°C for 30 min, centrifuged 10 min at 3,000 g, and the supernatant collected), 0.75 ml of PBS (with 0.9 mM Ca++ and 1 mM Mg++), 0.7 ml of a 2.5% agar solution in water, and 20 Ml of a 4 mg/ml solution of purified human plasminogen. This overlay mixture was prepared at 50°C and 100 ,u were applied to prewarmed 10 Am thick cryostat tissue sections mounted on poly-L-lysine-coated slides, and spread evenly under 24 x 32 mm glass coverslips. Slides were incubated at 37°C in humid chambers and zymograms were allowed to develop for 2-6 h. Identical experiments were carried out with overlay mixtures from which plasminogen was omitted or to which were added either I mM amiloride (28) , nonimmune goat or rabbit sera, specific anti-u-PA sera (rabbit anti-mouse u-PA serum, final dilution 1/50) (29), or specific anti-t-PA sera (goat anti-human t-PA serum, final dilution 1/50, provided by Dr. W. Schleuning, Berlin). The specificities of antibodies were verified by caseinolytic assays in solution using the conditioned medium of MSVtransformed 3T3 cells as a source of murine u-PA (30) and the conditioned medium of PYS cells as a source of murine t-PA (29) . Photographs were taken using dark-ground illumination.
Plasmid constructions, in vitro transcriptions, and Northern blot analysis. The u-PA antisense probe prepared from pSP64-MU, containing the 658-bp Pst I-Hind III fragment of the mouse u-PA cDNA clone pDB29 (31) , and the t-PA antisense probe from pSP64-MT3, containing the 726-bp Pvu II-Spe I fragment ofthe mouse t-PA cDNA clone pUC9-A33 (32) reduced to an average size of 50-100 nt by mild alkaline hydrolysis as previously described (7) .
Total RNAs were extracted as described elsewhere (33) . RNAs were denatured with glyoxal, electrophoresed in 1.2% agarose gels, and transferred overnight onto Biodyne nylon membranes (Pall Corp., Glen Cove, NY). Prehybridizations, hybridizations, and posthybridization washes were performed as previously described (34, 35) .
In situ hybridizations. Minor modifications were brought to the procedure previously described (7). 5-10 Mm cryostat tissue sections were mounted on poly-L-lysine (Sigma Chemical Co., St. Louis, MO) coated microscope slides, fixed in 4% glutaraldehyde in PBS for 1-5 min, rinsed in PBS, and stored in 70% ethanol at 4°C until analyzed. Prehybridizations, hybridizations, and posthybridization washes were carried out as described elsewhere (7). 1-3 x 106 cpm of 32P-labeled RNAs or 0.4-1 X 106 cpm of 3H-labeled RNAs were applied to each section in 20-70 Ml of hybridization mixture (7) . After graded ethanol dehydration, sections hybridized to 32P-labeled cRNAs were directly exposed to x-ray films (SB5; Eastman Kodak Co., Rochester, NY) between intensifying screens and the films developed after 3-5 d exposure at room temperature, while sections hybridized to 3H-labeled cRNAs were immersed in NTB-2 emulsion (Eastman Kodak), diluted 1:1 in deionized water. After 3-15 wk exposure, they were developed in Kodak D-19 developer, fixed in 30% Na thiosulfate, and counterstained in methylene blue.
Controls of specificity have been previously described (7, 35) , and included Northern blot hybridizations, the use of sense RNA probes and dot blot analysis under conditions of in situ hybridizations. For each experiment, control tissue sections of vas deferens and oviduct were included; these tissues contain, respectively and predominantly, u-PA and t-PA (7) . Photographs were taken with a conventional camera (Canon USA Inc., Lake Success, NY), using PANF black and white film (Ilford, Knutsford, Cheshire, England). Microphotographs were taken with a photomicroscope (Zeiss, Oberkochen, FRG), equipped with an immersion dark-field condensor, using Kodak Ektachrome 50 color film.
Results
Both u-PA and t-PA are synthesized by adult renal tissues and secreted in urine. Samples of urine were analyzed by SDS-PAGE followed by zymography. Two predominant types of PA were revealed in excreted urine ( Fig. 1 A, lane 4) that were inhibited by amiloride ( Fig. 1 B, lane 4) , a known inhibitor of urokinase catalytic activity (28) , and corresponded to the 48,000 and 28,000-Mr species ofmurine u-PA (30, 36 tions ofthe respective mRNAs. The u-PA cRNA probe labeled a well-defined zone of maximal intensity, corresponding to the outer stripe ofthe outer medulla, with a clear delineation ofthe medullary rays; a somewhat weaker signal was noticed in the inner stripe of the outer medulla, while the inner medulla and the papilla were negative. No signal was detected in the cortex (Fig. 3 A) . Hybridizations with the t-PA cRNA probe, performed on adjacent tissue sections, showed a contrasting distribution, with a predominant localization oft-PA mRNA in the papilla and in the inner medulla, and a weaker expression in the inner stripe of the outer medulla (Fig. 3 B) . A punctate signal was also evident in the cortex. The relative intensities of the signals obtained on Northern blots and by in situ hybridizations were comparable, u-PA mRNA being more abundant than t-PA mRNA (Fig. 2, A and B, lane 1, and Fig. 3, A and B) (37). The specificity of in situ hybridizations with these probes has already been established for other murine tissues (7, 35) ; furthermore, in the kidney, the specificity of in situ hybridizations is supported by the nonoverlapping distribution of the signals detected by two probes from related genes.
To assess whether these mRNAs are translated, the expression of PA enzymatic activity was visualized in situ by overlaying corresponding unfixed cryostat tissue sections with an agar solution containing plasminogen and casein. After 1-3 h of incubation at 37°C, distinct zones of caseinolysis were observed. Rapid substrate lysis occurred over the outer medulla (Fig. 3 C) that was inhibited by the u-PA inhibitor amiloride (Fig. 3 D) and anti-u-PA antibodies (Fig. 4, 1 C) . In the presence of amiloride and at later times, additional sites of proteolytic activity were observed over the papilla and glomeruli (Fig.  3 D) . This activity was abolished by anti-t-PA antibodies (Fig.  4, 2 B) , but not by anti-u-PA antibodies (Fig. 4, 1 C) . All activities were exclusively detected in the presence of plasminogen (Fig. 4, 1 A and B) , confirming that they were due to PAs. These results demonstrate the presence of u-PA in the outer medulla and oft-PA in glomeruli and in the papilla; they correlate with the hybridization studies and indicate that u-PA and t-PA mRNAs are translated.
The specificity of the zymographies on tissue sections used in the present study is supported by the requirement of plasminogen to visualize sites of caseinolysis, the inhibition of ca-A seinolytic activities with specific antibodies, and by the colocalizations ofcaseinolytic activities with mRNA distributions. To distinguish u-PA from t-PA, we found that amiloride was most useful for practical reasons, since it inhibits u-PA catalytic activity as effectively as specific antibodies. Other serine proteases are known to be produced by rodent kidney, such as esterase A (38) and kallikreins (39) ; although renal kallikreins can be inhibited by amiloride (40), they have been localized to regions of the nephron (41, 42) that differ clearly from those reported here for u-PA.
u-PA mRNA is present in epithelial cells ofstraight parts of proximal and distal tubules. To identify the sites of u-PA synthesis at the cellular level, tissue sections were hybridized to 3H-labeled probes and revealed by emulsion autoradiography. These hybridizations confirmed the restricted distribution of u-PA mRNA observed macroscopically. The epithelial cells from two different types of tubules were found to contain abundant u-PA mRNA (Fig. 5, A, B, C, and E) . The first type consisted of cells displaying a brush border, and present in tubules that had, on transverse sections, a large diameter without a visible lumen; these tubules, located in the outer stripe of the outer medulla (Fig. 5 , B, C, and E) were identified as the straight parts of proximal tubules; most, but not all, epithelial cells in these tubules were labeled. The second group oftubular cells labeled by the u-PA probe was associated with tubules of smaller diameter, that had a visible lumen on transverse sections (I and J), and that were present in the outer (Fig. 5, A, B , and C) and inner stripes (Fig. 5, F, G, H, I , and J) of the outer medulla; both their histological appearance and their distribution indicate that they correspond to the straight parts ofdistal tubules. In the inner stripe ofthe outer medulla, the labeling of the straight parts ofdistal tubules appeared to follow a segmental pattern, which could signify that u-PA mRNA is expressed by certain segments within the same tubule, or alternatively, that only a fraction of distal tubules express u-PA mRNA in their straight parts (Fig. 5 F) . It is of interest to note that the subcellular localization of autoradiographic grains differed in the two types of tubules: in the proximal tubules labeling was present in the perinuclear cytoplasm ofepithelial cells and was absent from the brush border region (Fig. 5 E) , while in distal tubules grains were predominantly visualized in the apical por- tion of epithelial cells (Fig. 5, B, C, G, H, I , and J); this difference remains presently unexplained. In contrast, convoluted proximal and distal tubules in the cortex were devoid of grains (Fig. 5, A and D) . Similarly, no signal was observed on glomeruli (Fig. 5 A) and on a type of tubules present in the inner stripe of outer medulla (Fig. 5, G and H) and in the inner medulla (Fig. 5 F) , that we interpret as collecting ducts. Though we did not recognize unambiguously Henle's loops in the outer and inner medullae, their potential contribution in u-PA mRNA expression is likely to be minimal, since no positive labeling was observed in the inner medulla, which contains numerous Henle's loops.
t-PA mRNA is present in epithelial cells ofdistal collecting ducts and in glomerular cells. Hybridizations with the 3H-labeled probe confirmed the presence of t-PA mRNA in the inner medulla and in the papilla. Labeling was detected predominantly over epithelial cells lining tubular structures that were concentrated in the tip of the papilla (Fig. 6, C, D , and E). These structures were identified as collecting ducts. In addition we observed a few positively labeled cells in the inner medulla that appear to reside outside tubular structures; t-PA mRNA may therefore also be present in interstitial or other cells.
As suggested by the macroscopic analysis with the 32P-labeled probe, glomeruli were found to express moderate amounts of t-PA mRNA (Fig. 6, A and B) . Due to the limitations of morphological resolution on cryostat tissue sections and to the low level of labeling, the positive cells could not be identified with certainty; they could represent endothelial, mesangial, or epithelial cells.
u-PA and t-PA are already synthesized by distinct cells in embryonic nephrons. Hybridizations to whole embryo tissue sections revealed that low amounts of u-PA and t-PA mRNAs are already detectable in the kidneys of 1 5.5-d old embryos (not shown). In 1 7.5-d old embryos, large amounts of u-PA mRNA were found in the central part of the kidney (Fig. 7 A) , while moderate amounts of t-PA mRNA were exclusively localized to the cortical area (Fig. 7 B) . Interestingly, at that stage of development, the kidney represented the site of highest u-PA mRNA abundance in the mouse embryo. Hybridizations with 3H-labeled probes showed that u-PA mRNA expression was confined to tubular cells, while t-PA mRNA was detected in epithelial cortical cells, constituting S-shaped bodies (not shown).
Zymographies performed in the presence of plasminogen on corresponding embryo tissue sections displayed a delineated zone of caseinolysis in an area that corresponded to the central part of the kidney (Fig. 7 C) . In the presence of plasminogen and amiloride, a zone of caseinolysis was detected on the cortical area, while no proteolysis could be seen on the central part of the kidney (Fig. 7 D) ; anti-u-PA antibodies also abolished the caseinolysis zone corresponding to the central part of the kidney, while the caseinolysis zone on the cortical area was unaffected (not shown). No caseinolysis was detected in the absence of plasminogen (not shown). These findings corroborate mRNA localizations and suggest that both PA mRNAs are translated at this stage of development. Other sites of major plasminogen-dependent caseinolysis were observed, for instance in intracranial structures and in the liver (Fig. 7) . Interestingly, neither u-PA nor t-PA mRNAs were detected in the fetal liver, raising the possibility that enzymatic activity might accumulate in the liver via the binding of enzymes to cell-surface receptors (8, 20, 21, 43) . This observation illustrates the potential discrepancy between the site of synthesis of a secreted protein and its site(s) of accumulation. 
Discussion
The proteolytic activity of human urine (44, 45) and its ability to dissolve fibrin clots (46, 47) have been recognized for many years. Fibrinolytic activities, which have since been detected in the various compartments of the urinary tract, have been predominantly ascribed to plasminogen activators (12, (48) (49) (50) (51) (52) . The kidney is now considered to be a prominent source of u-PA in all mammalian species studied so far (50, 51, 53) . However, the physiological roles of PAs in renal function remain speculative; since many renal disorders are characterized by excessive fibrin deposition, it has been postulated that these enzymes are involved in the prevention offibrin clot formation (18, 54) . The precise cellular sites ofPA synthesis in the urinary tubules have not been determined, though previous work performed on murine and human tissues, has shown u-PA immunoreactivity in tubular cells (15, 17) and t-PA immunoreactivity in glomerular cells ( 16, 1 7) . To assess the cellular sites ofPA production in the murine kidney, we localized PA mRNAs and documented the catalytic activity of PAs on histological sections.
We have shown that, in 17.5-d old mouse embryos, the kidney is the predominant site of u-PA gene expression, and that u-PA is synthesized exclusively by epithelial tubular cells residing in the central part of the kidney. Tissue section zymographies displayed a corresponding zone of plasminogendependent caseinolytic activity that was abolished by specific anti-u-PA antibodies and amiloride, indicating that the detected u-PA mRNA is translated. In the adult kidney, we localized u-PA mRNA in the epithelial cells of the straight parts of both proximal and distal tubules, whereas no signal was noticed in convoluted and collecting tubules. Histological zy-A mographies revealed that u-PA-catalyzed proteolytic activity was restricted to the regions of the kidney in which u-PA mRNA was most abundant. Large amounts of u-PA are recovered in urine, supporting the contention that most of the enzyme synthesized by tubular cells is released in urine; however, our results do not exclude a possible release of u-PA by tubular cells into the vascular compartment, via their basolateral pole, as proposed previously (16, 18, 55). We were not able to detect the presence of u-PA mRNA in glomerular cells, though u-PA has been identified in extracts of human glomeruli (16, 18, 55) or in cultures of glomerular epithelial cells ( 16); this apparent discrepancy might reflect species differences or, alternatively, in vitro differentiation features.
The observed segmental distribution of u-PA production might help define its potential contribution to renal function. The enzyme, which is produced and released by various cell types endowed with migratory and invasive properties, such as monocytes/macrophages (4, 5), trophoblasts (6, 7) , capillary endothelial cells (56) , and transformed cells (2) , has been predominantly related to tissue remodeling and invasion processes. Differentiated epithelial cells, such as those ofthe mammary gland, can also synthesize and secrete u-PA in a hormonally regulated fashion (34, 57) , a finding that has lead to the (28) . In addition to the caseinolytic zones observed over the kidney, plasminogen-dependent proteolytic activity was observed over the liver and the brain. Photographs were taken after 2 h (C) and 4 h (D) incubations at 37°C (X2.5).
assumption that u-PA might participate in the extensive tissue remodeling that accompanies glandular involution (57) . An alternate possibility, supported by work performed on the mammary gland (58) and the vas deferens (15, 35) , is that u-PA produced by certain epithelial cells might be involved in the maintenance ofductal fluidity. The epithelial cells that synthesize u-PA are located next to tubular segments where major water resorption occurs and which are therefore likely to be particularly exposed to protein precipitation. The u-PA produced and secreted at these sites might provide an efficient proteolytic mechanism to prevent tubular obstruction. This would imply the presence of plasminogen, or alternatively, the direct activity of u-PA on other protein substrates (59) in the urine that reaches the proximal and distal tubules. The presence ofplasminogen in the excretory tubules has not been documented, but appropriate amounts of this zymogen might be filtered, transuded, or actively secreted by tubular cells, as previously suggested (55) . The presence of active two-chain u-PA and of its M, 29 ,000 degradation product in urine supports the possibility that plasmin-mediated processes occur in tubules; indeed, plasmin catalyzes both the conversion of prou-PA into active u-PA and the generation of low molecular weight u-PA. Transient hematuria and proteinuria are known to occur during extreme physiological conditions, such as strenuous exercise, and numerous renal and systemic diseases are associated with hematuria and proteinuria; clinical studies have reported elevated u-PA production in glomerulonephritic patients, when compared with healthy volunteers (60), suggesting that u-PA production might be modulated by protein load in excretory tubules. In the absence of a potent proteolytic system, capable of digesting fibrin and/or other precipitated proteins, individual nephrons may become irreversibly plugged, a damage that, integrated over years, could lead to renal failure; the production of large amounts of u-PA by epithelial tubular cells, starting as soon as the nephron develops, may therefore be required for the preservation of tubule patency.
Maximal t-PA mRNA abundance was observed in distal portions of collecting ducts, which indicates that they are the major source oft-PA production in the kidney. The allocation of t-PA production to tubules has not been reported so far, though studies in dogs have reported PA activity in the tip of the papilla (51) . Tissue section zymographies showed the presence of plasminogen-dependent caseinolysis, selectively inhibited by anti-t-PA antibodies, at the sites where t-PA mRNA was detected. Although t-PA was barely detectable in excreted urine, in amounts comparable to those found in excreted human urine (61) , zymographic analysis of pelvic urine demonstrated the presence of high amounts of t-PA, providing evidence that the enzyme is secreted in urine and that it may participate in tubular physiology.
In conclusion, we demonstrate here that in the adult mouse kidney u-PA and t-PA are synthesized by distinct epithelial compartments and that both enzymes are secreted in urine. Though the differential distribution of u-PA and t-PA synthesis remains intriguing, these findings suggest that both enzymes may provide means to avoid the deleterious consequences of protein precipitation in tubules.
